Self-Help Intervention for Smoking Cessation in Cancer Patients

This study is looking at a new way to help people with cancer quit smoking. It's testing a "Targeted Self-Help" approach, which involves giving you a special booklet about smoking and your specific type of cancer (breast, colorectal, gynecological, skin melanoma, or bladder cancer). This booklet is designed to be easy to read and explain how smoking affects your cancer and the benefits of quitting. You would also receive "Usual Care" for quitting smoking. The study wants to see if this self-help booklet is practical and acceptable to patients, and if it helps increase your motivation to quit. They are looking for about 100 participants who have recently been diagnosed with one of these cancer types and smoke. The study is currently unclear on its recruitment status.

Study design
This interventional study plans to enroll 100 participants. It compares a "Targeted Self-Help" booklet plus usual care to usual care alone.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 1 month after randomization to assess completion of follow-up surveys.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06484179

Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type

Recruiting
NAAges 18+InterventionalPrevention
University of Utah
~100 participants
Updated 2025-11-26 on ClinicalTrials.gov
What's tested:Targeted Self-HelpUsual Care

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Recruitment
Measured over Baseline
+5 more outcomes measured
Cancer
Smoking
1 sites across 1 states
Utah1
  • Ursula Martinez, PhD · PRINCIPAL_INVESTIGATOR · Huntsman Cancer Institute

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Individuals who smoke and recently (i.e., within 6 months) received a diagnosis of breast, colorectal, gynecological, skin melanoma, or bladder cancer (n = 20 per cancer type). (Investigators will consider smokers individuals who report having smoked ≥1 cigarette in the past 30 days.)
Able to read/write English;
Able to give informed consent;
Not currently enrolled in a smoking cessation program;
Age ≥18 years old.

Exclusion

Male patients diagnosed with breast cancer will be excluded as lifetime risk for breast cancer in men is far below 1%
  • RecruitmentBaseline

    Number of participants who consent to participate in the study

  • Retention- Completion of 2-week follow-up2 weeks post-randomization

    Number of participants who complete the 2-week follow-up assessment

  • Retention- Completion of 1 month follow-up1 month post-randomization

    Number of participants who complete the 1 month follow-up assessment

  • Adherence- 2 weeks post-randomization2 weeks post-randomization

    Number of participants who read the booklet 2 weeks post-randomization

  • Adherence- 1 month post-randomization1 month post-randomization

    Number of participants who read the booklet 1 month post-randomization

  • Acceptability2 weeks post-randomization, 1 month post-randomization

    Treatment satisfaction measured with 8 items adapted from the Client Satisfaction Questionnaire. Values between 8 and 32 with higher scores indicating higher satisfaction.